Contract HT941024P0043
Medpharm Inc. · Department Of Defense · September 13, 2024
Medpharm Inc. was awarded a federal contract by Department Of Defense (Defense Health Agency) on September 13, 2024 for $23,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Agana Heights, GU. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 18, 2024. If all options are exercised, the contract could reach $229,000.
Contract details
- PIID
- HT941024P0043
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Agana Heights, GU
- First action
- September 13, 2024
- Latest action
- September 18, 2024
Description
COMPACT MAX 2 ANALYZER LEASE
Modification timeline
-
September 18, 2024Mod P00003 · Other Administrative Action$228.8K
-
September 17, 2024Mod P00002 · Supplemental Agreement For Work Within Scope$228.8K
-
September 13, 2024Mod P00001 · Supplemental Agreement For Work Within ScopeLEASE OF AND REGENTS FOR TWO COAGULATION ANALYZERS$228.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HT941024P0043?
Contract HT941024P0043 is a federal contract awarded to Medpharm Inc. by Department Of Defense on September 13, 2024 for $23,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract HT941024P0043?
Medpharm Inc. won contract HT941024P0043 from Department Of Defense.
How much is contract HT941024P0043 worth?
Contract HT941024P0043 has obligated $23,000 to date, with a total potential value of $229,000 if all options are exercised.